- Tel: 858.663.9055
-
Email: info@nsjbio.com
- Tel: 858.663.9055
- Email: info@nsjbio.com
Related Products
|
Integrin Alpha E Antibody rITGAE/2063 recognizes integrin alpha E, a cell-surface adhesion protein encoded by the ITGAE gene and commonly known as CD103. Integrin alpha E associates with integrin beta 7 to form the alpha E beta 7 heterodimer, a member of the beta 7 integrin subfamily. This receptor is particularly associated with lymphocyte populations residing within epithelial and mucosal tissues. Through interaction with E-cadherin, alpha E beta 7 contributes to the adhesion and retention of selected immune cells within epithelial compartments, connecting integrin alpha E expression with tissue localization and immune surveillance.
CD103 is widely used as a marker of intraepithelial lymphocytes and subsets of tissue-resident memory T cells. These immune populations can remain positioned within peripheral tissues and participate in localized responses to infection, inflammation and other changes in the tissue environment. Integrin alpha E expression is influenced by local signaling factors, including transforming growth factor beta, and is consequently studied in relation to lymphocyte differentiation, tissue residency and mucosal immunity. A Recombinant CD103 Antibody can therefore support research into both immune cell phenotype and mechanisms governing lymphocyte localization.
Integrin alpha E is also relevant to hematologic and cancer research. CD103 is strongly associated with hairy cell leukemia and is frequently investigated as part of the characteristic immunophenotype of this malignancy. Expression may additionally occur in selected T-cell and other lymphoid neoplasms. In solid tumor research, CD103-positive tumor-infiltrating lymphocytes are studied as tissue-resident immune populations and for their interactions with epithelial tumor compartments. These applications have made ITGAE an important target in studies connecting immune phenotype, cellular adhesion and the tumor microenvironment.
Clone rITGAE/2063 is a recombinant mouse monoclonal antibody directed against human ITGAE. Its recombinant format provides a defined antibody sequence while retaining recognition of the CD103/integrin alpha E target. NSJ Bioreagents offers clone rITGAE/2063 for research involving tissue-resident lymphocytes, mucosal immunity and CD103-associated immune biology. An Integrin Alpha E Antibody can provide a useful reagent for investigating ITGAE expression and the distribution of CD103-positive immune cell populations.
For broader CD103 validation including protein microarray analysis, see our CD103 Antibody ITGAE/2063 / Integrin Alpha E Monoclonal Antibody page.
Optimal dilution of the Integrin Alpha E Antibody rITGAE/2063 / Recombinant CD103 Antibody should be determined by the researcher.
Recombinant human ITGAE partial protein was used as the immunogen for the recombinant Integrin Alpha E Antibody rITGAE/2063.
Store the Integrin Alpha E Antibody rITGAE/2063 at 2-8oC (with azide) or aliquot and store at -20oC or colder (without azide).
CD103 antibody, ITGAE antibody, Integrin alpha E beta 7 antibody, alpha E integrin antibody, CD103 antigen antibody, HML-1 antigen antibody, Human mucosal lymphocyte antigen 1 antibody
Your bulk quote request has been submitted successfully!
Please contact us if you have any questions.